2022

1. Evaluation of the Feasibility, Safety and Efficacy of the Use of Intravenous Infusions of Adenosine Triphosphate (ATP) in People Affected by Moderate to Severe Alzheimer’s Disease: A Double-Blind Masked Clinical Trial for Dose Finding

   Journal of Prevention of Alzheimer's Disease, Vol. 9, Núm. 3, pp. 425-434